Ptc Therapeutics PTCT
NASDAQ PTCT
$69.73 -1.67 (-2.34%)
As of: Sep 4, 2026 · 2:27 PM EDT

Ptc Therapeutics (PTCT) Total Debt (QoQ) (2013 - 2026)

Analysis

Ptc Therapeutics (PTCT) Total Debt (QoQ) (2013 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.78 Bn 130.92 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.50 Bn 77.51 Bn 3.93 Bn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn
4 Moderna 58.06 Bn 52.92 Bn 52.00 Mn
5 Revolution Medicines 44.04 Bn 44.04 Bn -
6 BeOne Medicines 40.04 Bn 34.94 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.45 Bn 32.14 Bn 992.69 Mn
8 Royalty Pharma 28.41 Bn 27.57 Bn -
9 Insmed 27.42 Bn 26.26 Bn 358.27 Mn
10 Ptc Therapeutics 5.79 Bn 3.56 Bn 340.60 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.25%
Mar 31, 2026 0.66%
Dec 31, 2025 9.70%
Sep 30, 2025 0.55%
Jun 30, 2025 -0.12%
Mar 31, 2025 0.80%
Dec 31, 2024 -0.01%
Sep 30, 2024 -0.14%
Jun 30, 2024 13.37%
Mar 31, 2024 1.37%
Dec 31, 2023 137.66%
Sep 30, 2023 -0.43%
Jun 30, 2023 0.40%
Mar 31, 2023 0.75%
Dec 31, 2022 -0.03%
Sep 30, 2022 -8.68%
Jun 30, 2022 0.69%
Mar 31, 2022 0.04%
Dec 31, 2021 0.53%
Sep 30, 2021 15.62%